top of page
Products
Data
Opportunities
Partners
Press
About Us
Leadership
Our Story
Contact
Menu
Products
Data
Opportunities
Partners
Press
About Us
Leadership
Our Story
Contact
Close
Taran Therapeutics Presents Promising Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia and Secondary Acute Myeloid Leukemia Treatment
Taran Therapeutics
8 min read
Taran Therapeutics Reports Publication from PREACH-M Trial for Chronic Myelomonocytic Leukemia in Current Edition of the European Medical Journal
Taran Therapeutics
8 min read
Publication of Provisional Patent Application for Lenzilumab in Chronic Myelomonocytic Leukemia (CMML)
Taran Therapeutics
4 min read
Products
Data
Opportunities
Partners
Press
About Us
Leadership
Our Story
Contact
bottom of page
